95 related articles for article (PubMed ID: 28637988)
1. Comparison of gene expression profiles of gingival carcinoma Ca9-22 cells and colorectal adenocarcinoma HT-29 cells to identify potentially important mediators of SLPI-induced cell migration.
Takamura T; Suguro H; Mikami Y; Iwase T; Komiyama Y; Kuyama K; Komiyama K; Oki H
J Oral Sci; 2017; 59(2):279-287. PubMed ID: 28637988
[TBL] [Abstract][Full Text] [Related]
2. Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion.
Mikami Y; Fukushima A; Komiyama Y; Iwase T; Tsuda H; Higuchi Y; Hayakawa S; Kuyama K; Komiyama K
Cancer Lett; 2016 Aug; 379(1):84-93. PubMed ID: 27238568
[TBL] [Abstract][Full Text] [Related]
3. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
[TBL] [Abstract][Full Text] [Related]
4. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
Choi BD; Jeong SJ; Wang G; Park JJ; Lim DS; Kim BH; Cho YI; Kim CS; Jeong MJ
Int J Mol Med; 2011 Oct; 28(4):527-34. PubMed ID: 21687932
[TBL] [Abstract][Full Text] [Related]
5. SLPI facilitates cell migration by regulating lamellipodia/ruffles and desmosomes, in which Galectin4 plays an important role.
Mizutani Y; Omagari D; Hayatsu M; Nameta M; Komiyama K; Mikami Y; Ushiki T
Cell Adh Migr; 2020 Dec; 14(1):195-203. PubMed ID: 33016205
[TBL] [Abstract][Full Text] [Related]
6. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.
Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T
J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170
[TBL] [Abstract][Full Text] [Related]
7. Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT.
Wei Z; Liu G; Jia R; Zhang W; Li L; Zhang Y; Wang Z; Bai X
PeerJ; 2020; 8():e9400. PubMed ID: 32742768
[TBL] [Abstract][Full Text] [Related]
8. Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis.
Jan Treda C; Fukuhara T; Suzuki T; Nakamura A; Zaini J; Kikuchi T; Ebina M; Nukiwa T
Carcinogenesis; 2014 Apr; 35(4):896-904. PubMed ID: 24282288
[TBL] [Abstract][Full Text] [Related]
9. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.
Simpkins FA; Devoogdt NM; Rasool N; Tchabo NE; Alejandro EU; Kamrava MM; Kohn EC
Carcinogenesis; 2008 Mar; 29(3):466-72. PubMed ID: 17916899
[TBL] [Abstract][Full Text] [Related]
10. Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer.
Liu G; Yang J; Zhao Y; Wang Z; Xing B; Wang L; Shi D
World J Surg Oncol; 2014 Dec; 12():369. PubMed ID: 25441765
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer.
Cheng WL; Wang CS; Huang YH; Liang Y; Lin PY; Hsueh C; Wu YC; Chen WJ; Yu CJ; Lin SR; Lin KH
Int J Cancer; 2008 Oct; 123(8):1787-96. PubMed ID: 18688858
[TBL] [Abstract][Full Text] [Related]
12. Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.
Sayers KT; Brooks AD; Sayers TJ; Chertov O
PLoS One; 2014; 9(8):e104223. PubMed ID: 25110884
[TBL] [Abstract][Full Text] [Related]
13. High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.
Nugteren S; den Uil SH; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Stockmann HBAC; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
Sci Rep; 2022 Jul; 12(1):12174. PubMed ID: 35842496
[TBL] [Abstract][Full Text] [Related]
14. Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells.
Yu Y; Yu X; Ma J; Tong Y; Yao J
Int J Oncol; 2016 Jul; 49(1):285-93. PubMed ID: 27176231
[TBL] [Abstract][Full Text] [Related]
15. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.
Nugteren S; Goos JACM; Delis-van Diemen PM; Simons-Oosterhuis Y; Lindenbergh-Kortleve DJ; van Haaften DH; Sanders J; Meijer GA; Fijneman RJA; Samsom JN
Oncoimmunology; 2020 Oct; 9(1):1832761. PubMed ID: 33101778
[TBL] [Abstract][Full Text] [Related]
16. SLPI promotes the gastric cancer growth and metastasis by regulating the expression of P53, Bcl-2 and Caspase-8.
Du XY; Liu X; Wang ZJ; Wang YY
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1495-1501. PubMed ID: 28429358
[TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte protease inhibitor promotes differentiation and mineralization of MC3T3-E1 preosteoblasts on a titanium surface.
Choi BD; Lee SY; Jeong SJ; Lim DS; Cha HJ; Chung WG; Jeong MJ
Mol Med Rep; 2016 Aug; 14(2):1241-6. PubMed ID: 27279420
[TBL] [Abstract][Full Text] [Related]
18. Secretory leukocyte protease inhibitor in cancer development.
Devoogdt N; Revets H; Ghassabeh GH; De Baetselier P
Ann N Y Acad Sci; 2004 Dec; 1028():380-9. PubMed ID: 15650263
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps.
Zabieglo K; Majewski P; Majchrzak-Gorecka M; Wlodarczyk A; Grygier B; Zegar A; Kapinska-Mrowiecka M; Naskalska A; Pyrc K; Dubin A; Wahl SM; Cichy J
J Leukoc Biol; 2015 Jul; 98(1):99-106. PubMed ID: 25917460
[TBL] [Abstract][Full Text] [Related]
20. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
